Mortality from epilepsy and status epilepticus in Brazil: analysis of the epidemiological profile
DOI:
https://doi.org/10.33448/rsd-v11i14.35922Keywords:
Mortality; Epilepsy; Status epilepticus; Epidemiology.Abstract
The objective of this article was to carry out an epidemiological analysis of the mortality profile from epilepsy and status epilepticus in Brazil. Methods: Retrospective transversal epidemiological study, with a quantitative and descriptive approach using data obtained from the Mortality Information System (MIS), according to sex and age group, between 2010 and 2019. Results: A total of 25,393 deaths were identified in Brazil, 89.8% of which were due to epilepsy (MPE) and 10.2% due to status epilepticus (EME). Of the total, 64.3% were male and 35.7% were female. The majority of cases were between 40 and 49 years. The North and Northeast regions presented the highest percentage of MPE and EME. In relation to the general mortality rates, an increase of 46.9% (MPE) and 68.4% (EME) was identified, with an increase in all geographic regions. The population mortality rate from epilepsy followed an upward trend with no statistically significant fluctuations. The mortality rate due to EME showed an increase between the general population and the male population, with an indication of a decrease among the female population. Conclusions: Contrary to the global parameter, Brazil showed an increase in the mortality rate from epilepsy, which may be related to the improvement in diagnosis, in the adequate recording of the underlying cause of death and in MIS in the last Years.
References
Abdel-Mannan, O., Hughes, E., & Dunkley, C. (2020). Epilepsy deaths in children: Improvements driven by data and surveillance in pediatrics. Epilepsy & behavior: E&B, 103(Pt B), 106493. https://doi.org/10.1016/j.yebeh.2019.106493
Beghi E. (2020). The Epidemiology of Epilepsy. Neuroepidemiology, 54(2), 185–191. https://doi.org/10.1159/000503831
Bell G. S., Neligan A., & Sander J. W. (2014). An unknown quantity–the worldwide prevalence of epilepsy. Epilepsia, 55(7), 958-962.
Bertolucci P. H. F., Ferraz H. B., Félix E. P. V., & Pedroso J. L. (2011). Neurologia. São Paulo: Manole. p. 1140.
Der-Nigoghossian, C., Rubinos, C., Alkhachroum, A., & Claassen, J. (2019). Status epilepticus - time is brain and treatment considerations. Current opinion in critical care, 25(6), 638–646. https://doi.org/10.1097/MCC.0000000000000661
Devinsky, O., Spruill, T., Thurman, D., & Friedman, D. (2016). Recognizing and preventing epilepsy-related mortality: A call for action. Neurology, 86(8), 779–786. https://doi.org/10.1212/WNL.0000000000002253
Dwivedi, R., Ramanujam, B., Chandra, P. S., Sapra, S., Gulati, S., Kalaivani, M., Garg, A., Bal, C. S., Tripathi, M., Dwivedi, S. N., Sagar, R., Sarkar, C., & Tripathi, M. (2017). Surgery for drug-resistant epilepsy in children. N Engl J Med, 377 (17), 1639–1647
Escalaya, A. L., Tellez-Zenteno, J. F., Steven, D. A., & Burneo, J. G. (2015). Epilepsy and mortality in Latin America. Seizure, 25, 99–103. https://doi.org/10.1016/j.seizure.2014.09.012
Fernandes M. J. S. (2013). Epilepsia do lobo temporal: mecanismos e perspectivas. Estudos Avançados, 27(77), 85-98.
Ferrari, C. M., de Sousa, R. M., & Castro, L. H. (2013). Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure, 22(5), 384–389. https://doi.org/10.1016/j.seizure.2013.02.006
Ferreira, I. L. M., & Silva, T. P. T. (2009). Mortalidade por epilepsia no Brasil, 1980-2003. Cien Saude Colet, 14(1), 89-94.
Fisher, R. S., Van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. Jr (2005). Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 46(4), 470-472.
Garzon, E. (2008). Estado de Mal Epiléptico. J Epilepsy Clin Neurophysiol, 14 (Suppl 2), 7-11.
GBD 2016 Epilepsy Collaborators (2019). Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, 18(4), 357–375. https://doi.org/10.1016/S1474-4422(18)30454-X
Gomes, M. M. (2010). Mortalidade atribuída à epilepsia, às suas doenças subjacentes ou às condições não relacionadas a ela: uma síntese. J. epilepsy clin. neurophysiol. 16(3), 100-105. https://doi.org/10.1590/S1676-26492010000300004
Gomes, M. M. (2011) Mortality from epilepsy: Brazil (capitals), 1980-2007. Arq. Neuropsiquiatr., 69(2), 166-169. https://doi.org/10.1590/S0004-282X2011000200004
Instituto Brasileiro de Geografia e Estatística. (2018). Projeção da População do IBGE.
Johnson, E. L., & Kaplan, P. W. (2020). Status Epilepticus: Definition, Classification, Pathophysiology, and Epidemiology. Seminars in neurology, 40(6), 647–651. https://doi.org/10.1055/s-0040-1718722
Kellinghaus, C., Rossetti, A. O., Trinka, E., Lang, N., May, T. W., Unterberger, I., Rüegg, S., Sutter, R., Strzelczyk, A., Tilz, C., Uzelac, Z., & Rosenow, F. (2019). Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE). Annals of neurology, 85(3), 421–432. https://doi.org/10.1002/ana.25416
Kwon, C. S., Ripa, V., Al-Awar, O., Panov, F., Ghatan, S., & Jetté, N. (2018). Epilepsy and neuromodulation - randomized controlled trials. Brain Sci, 8(4), 69
Leitinger, M., Trinka, E., Giovannini, G., Zimmermann, G., Florea, C., Rohracher, A., Kalss, G., Neuray, C., Kreidenhuber, R., Höfler, J., Kuchukhidze, G., Granbichler, C., Dobesberger, J., Novak, H. F., Pilz, G., Meletti, S., & Siebert, U. (2019). Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia, 60(1), 53–62. https://doi.org/10.1111/epi.14607
Levira, F., Thurman, D. J., Sander, J. W., Hauser, W. A., Hesdorffer, D. C., Masanja, H., Odermatt, P., Logroscino, G., Newton, C. R., & Epidemiology Commission of the International League Against Epilepsy (2017). Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia, 58(1), 6–16. https://doi.org/10.1111/epi.13603
Lv, R. J., Wang, Q., Cui, T., Zhu, F., & Shao, X. Q. (2017). Status epilepticus-related etiology, incidence and mortality: A meta-analysis. Epilepsy research, 136, 12–17. https://doi.org/10.1016/j.eplepsyres.2017.07.006
Meyer, A. C., Dua, T., Ma, J., Saxena, S., & Birbeck, G. (2010). Global disparities in the epilepsy treatment gap: a systematic review. Bulletin of the World Health Organization, 88(4), 260–266. https://doi.org/10.2471/BLT.09.064147
Ministério da Saúde (2019). Protocolo Clínico e Diretrizes Terapêuticas para Epilepsia. Brasília: CONITEC.
Ministério da Saúde. Sistema de Informações sobre Mortalidade. http://www2.datasus.gov.br/DATASUS/index.php?area=060701
Moshé S. L., Perucca E., Ryvlin P., & Tomson T. (2015). Epilepsy: new advances. Lancet, 385(9971), 884-898.
National Institute for Health and Care Excellence. (2014). Transient loss of consciousness (‘blackouts’) in over 16s.
National Institute for Health and Care Excellence. (2018). Epilepsies: diagnosis and management. 1-636.
Neligan, A., Hauser, W. A., & Sander, J. W. (2012). The epidemiology of the epilepsies. Handb Clin Neurol, 107, 113-133.
Neligan, A., Noyce, A. J., Gosavi, T. D., Shorvon, S. D., Köhler, S., & Walker, M. C. (2019). Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time: A Systematic Review and Meta-analysis. JAMA neurology, 76(8), 897–905. https://doi.org/10.1001/jamaneurol.2019.1268
Panelli, R. J., & O'Brien, T. J. (2019). Epilepsy and seizure-related deaths: Mortality statistics do not tell the complete story. Epilepsy & behavior: E&B, 98(Pt A), 266–272. https://doi.org/10.1016/j.yebeh.2019.07.003
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Método Qualitativo, Quantitativo ou Quali-Quanti. In: Metodologia da Pesquisa Científica. Santa Maria, 67-69.
Rede Interagencial de Informações para Saúde (RIPSA). (2020). Taxa de mortalidade específica por causas externas (coeficiente de mortalidade específica por causas externas). Brasília – DF.
Ryvlin, P., Cross, J. H., & Rheims, S. (2014). Epilepsy surgery in children and adults. Lancet Neurol, 13(11), 1114-1126.
Sella, F., Seisdedos, R. A., & Barros, C. R. M. R. (2016). Perfil epidemiológico dos membros de uma associação de epilepsia em Santa Catarina. Arquivos Catarinenses de Medicina, 45(2), 59-66.
Shorvon, S., & Sem, A. (2020) What is status epilepticus and what do we know about its epidemiology? Seizure, 75, 131-136.
Singh, A., & Trevick, S. (2016). The epidemiology of global epilepsy. Neurol Clin, 34(4), 837-847.
Singh, G., & Sander, J. W. (2020). The global burden of epilepsy report: Implications for low- and middle-income countries. Epilepsy & behavior: E&B, 105, 106949. https://doi.org/10.1016/j.yebeh.2020.106949
Soares, D. A., Andrade, S. M., & Campos, J. J. B. (2017). Epidemiologia e indicadores de saúde. In: Andrade, S. M., Cordoni Jr, L. et al. Bases da saúde coletiva. Londrina: Eduel, 183-210.
Stelzer, F. G., Bustamante, G. O., Sander, H., Sakamoto, A. C., & Fernandes, R. M. F. (2015) Short-term mortality and prognostic factors related to status epilepticus. Arq. Neuropsiquiatr., 73(8), 670-675. https://doi.org/10.1590/0004-282X20150082
Sveinsson, O., Andersson, T., Mattsson, P., Carlsson, S., & Tomson, T. (2020). Clinical risk factors in SUDEP: A nationwide population-based case-control study. Neurology, 94(4), e419–e429. https://doi.org/10.1212/WNL.0000000000008741
Watila, M. M., Balarabe, S. A., Ojo, O., Keezer, M. R., & Sander, J. W. (2018). Overall and cause-specific premature mortality in epilepsy: A systematic review. Epilepsy & behavior: E&B, 87, 213–225. https://doi.org/10.1016/j.yebeh.2018.07.017
Wiebe, S., Blume, W. T., Girvin, J. P., & Eliasziw, M. (2001). Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med, 345(5), 311–318.
World Health Organization. (2019). Epilepsy: a public health imperative. Summary. WHO.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Luana Jaçanã Resende dos Santos Tavares; Fernanda Gessica da Silva Duarte; Rafael Simplicio Martins; Elane de Nazaré Magno Ferreira; Isaias Fiúza Cabral
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
